Clinical trial

Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure

NCT02591173

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Angiotensin-(1-7) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Saline Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure

Design: INTERVENTIONAL · Status: TERMINATED · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-02-01

PhaseEARLY_PHASE1

Conditions

Autonomic Nervous System Disordersunresolved

Pure Autonomic Failureverified · MONDO: pure autonomic failure

Shy-Drager Syndromeverified · MONDO: multiple system atrophy

Orthostatic Hypotension, Dysautonomicunresolved

Interventions

Angiotensin-(1-7)DRUG

SalineDRUG

Sponsors & collaborators

Vanderbilt University Medical Centerlead sponsor

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02591173 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.